OccamzRazor Company

OccamzRazor combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development. Our analysis pipeline consists of two proprietary technologies, Panoramic AI and RazorBrain. Together, they are designed to extract data from unstructured text sources (publications, patient reported outcomes, etc.) and join them with structured data (genomics, proteomics, phenomics, etc.) to generate stronger drug discovery hypotheses and more valuable insights. Successful applications include data extraction and curation from biomedical text, novel target identification, and drug repurposing/repositioning.
Technology: Artificial Intelligence, Machine Learning, Neuroscience
Industry: Early Drug Development
Headquarters: San Francisco, California, United States
Founded Date: 2015-10-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 12
Total Funding: 12350000
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-07-23
Last Funding Type: Series A

Visit Website
Register and Claim Ownership